BlackRock Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $249K | Sell |
4,111
-81
| -2% | -$4.91K | ﹤0.01% | 2533 |
|
2016
Q3 | $278K | Buy |
4,192
+217
| +5% | +$14.4K | ﹤0.01% | 2441 |
|
2016
Q2 | $222K | Buy |
3,975
+230
| +6% | +$12.8K | ﹤0.01% | 2500 |
|
2016
Q1 | $126K | Sell |
3,745
-13,762
| -79% | -$463K | ﹤0.01% | 2755 |
|
2015
Q4 | $790K | Buy |
17,507
+12,412
| +244% | +$560K | ﹤0.01% | 1814 |
|
2015
Q3 | $201K | Sell |
5,095
-401
| -7% | -$15.8K | ﹤0.01% | 2688 |
|
2015
Q2 | $341K | Buy |
5,496
+718
| +15% | +$44.5K | ﹤0.01% | 2418 |
|
2015
Q1 | $299K | Buy |
4,778
+612
| +15% | +$38.3K | ﹤0.01% | 2422 |
|
2014
Q4 | $235K | Sell |
4,166
-412
| -9% | -$23.2K | ﹤0.01% | 2502 |
|
2014
Q3 | $129K | Sell |
4,578
-459
| -9% | -$12.9K | ﹤0.01% | 2831 |
|
2014
Q2 | $173K | Buy |
5,037
+2,876
| +133% | +$98.8K | ﹤0.01% | 2685 |
|
2014
Q1 | $68K | Hold |
2,161
| – | – | ﹤0.01% | 3152 |
|
2013
Q4 | $43K | Hold |
2,161
| – | – | ﹤0.01% | 3250 |
|
2013
Q3 | $21K | Buy |
2,161
+664
| +44% | +$6.45K | ﹤0.01% | 3297 |
|
2013
Q2 | $9K | Buy |
+1,497
| New | +$9K | ﹤0.01% | 3428 |
|